SOLIFENACIN/TAMSULOSIN NORMON 6 mg/0.4 mg MODIFIED-RELEASE TABLETS

2. What you need to know before you take Solifenacin/Tamsulosin Normon

Do not take Solifenacin/Tamsulosin Normon

• If you are allergic to solifenacin or tamsulosin or any of the other ingredients of this medicine (listed in section 6).
• If you are undergoing renal dialysis.
• If you have severe liver disease.
• If you have severe kidney disease and if, at the same time, you are being treated with medicines that may decrease the elimination of solifenacin/tamsulosin from the body (e.g. ketoconazole, ritonavir, nelfinavir, itraconazole). Your doctor or pharmacist will inform you if this is the case.
• If you have moderate liver disease and if, at the same time, you are being treated with medicines that may decrease the elimination of solifenacin/tamsulosin from the body (e.g. ketoconazole, ritonavir, nelfinavir, itraconazole). Your doctor or pharmacist will inform you if this is the case.
• If you have a severe stomach or intestinal condition (including toxic megacolon, a complication associated with ulcerative colitis).
• If you have a muscle disease called myasthenia gravis, which can cause extreme weakness of certain muscles.
• If you have increased pressure in the eyes (glaucoma), with gradual loss of vision.
• If you experience fainting due to a decrease in blood pressure when changing position (when sitting or standing up); this is called orthostatic hypotension.

Tell your doctor if you think you have any of these conditions.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Solifenacin/Tamsulosin Normon:

• If you have difficulty eliminating fluid (urinary retention).
• If you have any obstruction of the digestive system.
• If you have a risk of decreased activity of the digestive system (movements of the stomach and intestine). Your doctor will inform you if this is the case.
• If you have a tear in the diaphragm (hiatal hernia) or heartburn and/or if, at the same time, you are taking medicines that may cause or worsen esophagitis.
• If you have a certain type of nerve disease (autonomic neuropathy).
• If you have severe kidney disease.
• If you have moderate liver disease.

Regular medical check-ups are necessary to monitor the development of the condition for which you are being treated.

This medicine may affect blood pressure, which can cause dizziness, drowsiness, or rarely, fainting (orthostatic hypotension). You should sit or lie down if you experience any of these symptoms until they have disappeared.

If you are going to undergo or have scheduled eye surgery due to cataracts or increased pressure in the eyes (glaucoma), please inform your ophthalmologist that you have previously used, are using, or plan to use solifenacin/tamsulosin. The specialist can then take the necessary precautions regarding medication and surgical techniques to be used. Ask your doctor if you should delay or temporarily interrupt taking this medicine when you are going to undergo eye surgery for cataracts or increased pressure in the eye (glaucoma).

Children and adolescents

Do not give this medicine to children and adolescents.

Other medicines and Solifenacin/Tamsulosin Normon

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

It is especially important that you inform your doctor if you are using:

• Medicines such as ketoconazole, erythromycin, ritonavir, nelfinavir, itraconazole, verapamil, diltiazem, and paroxetine, which reduce the rate at which solifenacin/tamsulosin is eliminated from the body.
• Other anticholinergic medicines, as the effects and side effects of both medicines can be intensified if you are taking two medicines of the same type.
• Cholinergics, as they may reduce the effect of solifenacin/tamsulosin.
• Medicines such as metoclopramide and cisapride, which can accelerate the functioning of the digestive system. Solifenacin/tamsulosin may reduce their effect.
• Other alpha-blockers (used to decrease blood pressure), as they may cause an undesired drop in blood pressure.
• Medicines such as bisphosphonates, which may cause or exacerbate inflammation of the esophagus (esophagitis).

Taking Solifenacin/Tamsulosin Normon with food and drinks

Solifenacin/tamsulosin can be taken with or without food, according to your preferences.

Pregnancy, breastfeeding, and fertility

Solifenacin/tamsulosin is not indicated for use in women.

In men, abnormal ejaculation (ejaculation disorder) has been reported. This means that the semen is not released through the urethra, but instead goes into the bladder (retrograde ejaculation) or that the ejaculated volume is reduced or nonexistent (ejaculatory failure). This phenomenon is harmless.

Driving and using machines

This medicine may cause dizziness, blurred vision, fatigue, and less frequently, drowsiness. If you experience these side effects, do not drive or use machines.

3. How to take Solifenacin/Tamsulosin Normon

Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The maximum daily dose is one tablet containing 6 mg of solifenacin and 0.4 mg of tamsulosin, taken orally. It can be taken with or without food, depending on your preferences. Do not crush or chew the tablet.

If you take more Solifenacin/Tamsulosin Normon than you should

If you have taken more tablets than you were told to, or if someone else has taken your tablets by mistake, contact your doctor, pharmacist, or hospital immediately for advice.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.

In case of overdose, your doctor may treat you with activated charcoal; emergency stomach lavage may be useful if performed within one hour of the overdose. Do not induce vomiting.

The symptoms of overdose may include: dry mouth, dizziness, and blurred vision, seeing things that are not there (hallucinations), over-excitability, convulsions, difficulty breathing, increased heart rate (tachycardia), inability to empty the bladder completely or partially or to urinate (urinary retention), and/or undesired increase in blood pressure.

If you forget to take Solifenacin/Tamsulosin Normon

Take your next solifenacin/tamsulosin tablet as normal. Do not take a double dose to make up for forgotten doses.

If you stop taking Solifenacin/Tamsulosin Normon

If you stop taking this medicine, your initial symptoms may reappear or worsen. Always consult your doctor if you are considering stopping treatment.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The most serious side effect that has been observed with a frequency of less than 1 in 100 men during treatment with solifenacin, succinate/tamsulosin, hydrochloride in clinical studies is acute urinary retention, which is a sudden inability to urinate. If you think you may have this, go to your doctor immediately. You may need to stop taking this medicine.

Solifenacin/Tamsulosin may cause allergic reactions:

• Uncommon signs of allergic reactions may include skin rash (which can be itchy) or hives (urticaria).
• Rare symptoms include swelling of the face, lips, mouth, tongue, or throat, which can cause difficulty swallowing or breathing (angioedema). Angioedema has been reported rarely with tamsulosin and very rarely with solifenacin. In case of angioedema, treatment with this medicine should be stopped immediately and definitively.

If you experience an allergic reaction or a severe skin reaction (e.g. blistering and peeling of the skin), you should inform your doctor immediately and stop using this medicine. Treatment and/or measures should be applied.

Other side effects:

Common side effects (may affect up to 1 in 10 men)

• Dry mouth.
• Constipation.
• Indigestion (dyspepsia).
• Dizziness.
• Blurred vision.
• Fatigue.
• Abnormal ejaculation (ejaculation disorder). This means that the semen is not released through the urethra, but instead goes into the bladder (retrograde ejaculation) or that the ejaculated volume is reduced or nonexistent (ejaculatory failure). This phenomenon is harmless.
• Feeling of nausea.
• Abdominal pain.

Uncommon side effects (may affect up to 1 in 100 men)

• Drowsiness.
• Itching (pruritus).
• Skin rash.
• Urinary tract infection, bladder infection (cystitis).
• Taste disorder (dysgeusia).
• Dry eyes.
• Dry nose.
• Gastroesophageal reflux disease.
• Dry throat.
• Dry skin.

• Difficulty urinating.
• Fluid accumulation in the legs (peripheral edema).
• Headache.
• Fast or irregular heartbeat (palpitations).
• Feeling of dizziness or weakness, especially when standing up (orthostatic hypotension).
• Nasal congestion or stuffiness (rhinitis).
• Diarrhea.
• Vomiting.
• Fatigue (asthenia).

Rare side effects (may affect up to 1 in 1,000 men)

• A large amount of hardened feces accumulating in the large intestine (fecal impaction).
• Feeling of fainting (syncope).
• Allergic reaction in the skin that causes swelling in the tissue under the skin surface (angioedema).

Very rare side effects (may affect up to 1 in 10,000 men)

• Hallucinations, confusion.
• Allergic reaction in the skin (erythema multiforme).
• Prolonged and painful erection (usually not during sexual activity) (priapism).
• Inflammation and blistering of the skin and/or mucous membranes of the lips, eyes, mouth, nasal passages, or genitals (Stevens-Johnson syndrome).

Frequency not known (cannot be estimated from the available data)

• Anaphylactic reaction (sudden and severe allergic reaction with difficulty breathing, swelling, dizziness, rapid heartbeat, sweating, and loss of consciousness).
• Decreased appetite.
• High levels of potassium in the blood (hyperkalemia) that can cause abnormal heart rhythm.
• Increased pressure in the eyes (glaucoma).
• Irregular or abnormal heartbeat (prolonged QT interval, Torsades de Pointes, atrial fibrillation, arrhythmia).
• Fast heartbeat (tachycardia).
• Breathing difficulties (dyspnea).
• During eye surgery for cataracts or increased pressure in the eye (glaucoma), it is possible that the pupil (the black circle in the center of the eye) may not increase in size properly. Additionally, the iris (the colored part of the eye) may become flaccid during surgery.
• Voice disorder.
• Liver disorder.
• Muscle weakness.
• Kidney disorder.
• Vision disorder.
• Nosebleed (epistaxis).
• Psychiatric disorders such as confusion (delirium).
• Abdominal discomfort.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Agency's Pharmacovigilance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Solifenacin/Tamsulosin Normon

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton or blister after EXP. The expiry date is the last day of the month stated.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Container Content and Additional Information

Composition of Solifenacin/Tamsulosin Normon

• The active ingredients are solifenacin succinate and tamsulosin hydrochloride. Each modified-release tablet contains 6 mg of solifenacin succinate and 0.4 mg of tamsulosin hydrochloride.
• The other ingredients are: high molecular weight macrogol, anhydrous colloidal silica (E551), magnesium stearate (E470b), calcium hydrogen phosphate (E341), microcrystalline cellulose (E460), silicified microcrystalline cellulose

(anhydrous colloidal silica and microcrystalline cellulose), low-substituted hydroxypropylcellulose (E463), hypromellose (E464), red iron oxide (E172), macrogol, and butylhydroxytoluene (E321).

Appearance of the Product and Container Content

Solifenacin/Tamsulosin Normon 6 mg/0.4 mg modified-release tablets are round, biconvex, film-coated tablets of red color, with «6 04» engraved on one face and with a diameter of 9 mm.

Solifenacin/Tamsulosin Normon is available in PA/aluminum/PVC/aluminum blister packs or in single-dose PA/aluminum/PVC/aluminum precut blisters.

Packs of 30 tablets (in blisters).

Packs of 30 x 1 tablet (in single-dose precut blisters).

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

LABORATORIOS NORMON, S.A.

Ronda de Valdecarrizo, 6 - 28760 Tres Cantos - Madrid (SPAIN)

Manufacturer

ADAMED PHARMA S.A.

ul. Marszalka Józefa Pilsudskiego 5

95-200 Pabianice

Poland

Or

ADALVO LIMITED

Malta Life Sciences Park, Building 1 Level 4

Sir Temi Zammit Buildings

San Gwann SGN 3000

Malta

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Spain: Solifenacin/Tamsulosin Normon 6 mg/0.4 mg modified-release tablets EFG

Date of the last revision of this leaflet: January 2023

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).

You can access detailed and updated information about this medicinal product by scanning the QR code included in the leaflet and packaging with your mobile phone (smartphone). You can also access this information at the following internet address:

https://cima.aemps.es/cima/dochtml/p/88710/P_88710.html